Arbutus Biopharma Corp (Pre-Merger)

Arbutus Biopharma Corp recorded insider activity involving Christopher Naftzger, who executed a planned purchase of 2,477 shares on December 31, 2024. Previously, Michael Joseph Sofia sold 9,982 shares on February 2, 2024. These transactions represent the most recent documented movements by company leadership.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Insider activity signals

0 activity signals detected for Arbutus Biopharma Corp (Pre-Merger)

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Naftzger, Christopher Senior Officer of Issuer Officer

Transaction date 31 Dec 2024

Planned purchase

Price

351.85

Quantity 45,915 +36.1%

Value US$1,624,641

Sofia, Michael Joseph Senior Officer of Issuer Officer

Transaction date 2 Feb 2024

Sale

Price

132.18

Quantity 4,227 -48.4%

Value US$1,977,599

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-02-20	2024-12-31	PP Planned purchase	Naftzger, Christopher Senior Officer of Issuer Officer	45,915 +36.1% 351.85 US$1,624,641	45,915 +36.1%	351.85	US$1,624,641
2024-02-05	2024-02-02	S Sale	Sofia, Michael Joseph Senior Officer of Issuer Officer	4,227 -48.4% 132.18 US$1,977,599	4,227 -48.4%	132.18	US$1,977,599